Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Sevion Therapeutics (SVON)

Sevion Therapeutics (SVON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 16,788
  • Shares Outstanding, K 55,960
  • Annual Sales, $ 0 K
  • Annual Income, $ -5,800 K
  • 60-Month Beta 1.38
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.66
Trade SVON with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.11
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date 02/09/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2601 +15.34%
on 11/21/17
0.4400 -31.82%
on 11/28/17
+0.0400 (+15.38%)
since 11/17/17
3-Month
0.1950 +53.85%
on 10/27/17
0.4400 -31.82%
on 11/28/17
+0.0601 (+25.05%)
since 09/19/17
52-Week
0.1300 +130.77%
on 12/23/16
0.4400 -31.82%
on 11/28/17
+0.1640 (+120.59%)
since 12/19/16

Business Summary

Sevion is a biopharmaceutical company which discovers and develops entirely new therapeutic classes for the treatment of cancer and immunological diseases. The Company's product candidates are derived from multiple key proprietary technology platforms: cell-based arrayed antibody discovery, ultra long...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 0.3933
1st Resistance Point 0.3467
Last Price 0.3000
1st Support Level 0.2717
2nd Support Level 0.2433
3rd Support Level N/A

See More

52-Week High 0.4400
Fibonacci 61.8% 0.3216
Last Price 0.3000
Fibonacci 50% 0.2850
Fibonacci 38.2% 0.2484
52-Week Low 0.1300

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar